Literature DB >> 19236225

Computational toxicology: an overview of the sources of data and of modelling methods.

Florian Nigsch1, N J Maximilan Macaluso, John B O Mitchell, Donatas Zmuidinavicius.   

Abstract

BACKGROUND: Toxicology has the goal of ensuring the safety of humans, animals and the environment. Computational toxicology is an area of active development and great potential. There are tangible reasons for the emerging interest in this discipline from academia, industry, regulatory bodies and governments.
RESULTS: Pharmaceuticals, personal health care products, nutritional ingredients and products of the chemical industries are all potential hazards and need to be assessed. Toxicological tests for these products are costly, frequently use laboratory animals and are time-consuming. This delays end-user access to improved products or, conversely, the timely withdrawal of dangerous substances from the market. The aim of computational toxicology is to accelerate the assessment of potentially dangerous substances through in silico models.
CONCLUSIONS: In this review, we provide an overview of the development of models for computational toxicology. Addressing the significant divide between the experimental and computational worlds-believed to be a prime hindrance to computational toxicology-we briefly consider the fundamental issue of toxicological data and the assays they stem from. Different kinds of models that can be built using such data are presented: computational filters, models for specific toxicological endpoints and tools for the generation of testable hypotheses.

Entities:  

Mesh:

Year:  2009        PMID: 19236225     DOI: 10.1517/17425250802660467

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  12 in total

1.  Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data.

Authors:  Ivan Rusyn; Alexander Sedykh; Yen Low; Kathryn Z Guyton; Alexander Tropsha
Journal:  Toxicol Sci       Date:  2012-03-02       Impact factor: 4.849

2.  iFad: an integrative factor analysis model for drug-pathway association inference.

Authors:  Haisu Ma; Hongyu Zhao
Journal:  Bioinformatics       Date:  2012-05-10       Impact factor: 6.937

3.  Shaping the future of safer innovative drugs in Europe.

Authors:  Jordi Mestres; Sharon D Bryant; Ismael Zamora; Johann Gasteiger
Journal:  Nat Biotechnol       Date:  2011-09-08       Impact factor: 54.908

Review 4.  Paradigm shift in toxicity testing and modeling.

Authors:  Hongmao Sun; Menghang Xia; Christopher P Austin; Ruili Huang
Journal:  AAPS J       Date:  2012-04-20       Impact factor: 4.009

5.  3D QSAR studies of hydroxylated polychlorinated biphenyls as potential xenoestrogens.

Authors:  Patricia Ruiz; Kundan Ingale; John S Wheeler; Moiz Mumtaz
Journal:  Chemosphere       Date:  2015-11-19       Impact factor: 7.086

6.  Computational toxicology: realizing the promise of the toxicity testing in the 21st century.

Authors:  Ivan Rusyn; George P Daston
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

7.  In silico toxicology - non-testing methods.

Authors:  Hannu Raunio
Journal:  Front Pharmacol       Date:  2011-06-30       Impact factor: 5.810

8.  Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge.

Authors:  Julian E Fuchs; Andreas Bender; Robert C Glen
Journal:  Mol Inform       Date:  2015-03-10       Impact factor: 3.353

Review 9.  Alternatives to In Vivo Draize Rabbit Eye and Skin Irritation Tests with a Focus on 3D Reconstructed Human Cornea-Like Epithelium and Epidermis Models.

Authors:  Miri Lee; Jee-Hyun Hwang; Kyung-Min Lim
Journal:  Toxicol Res       Date:  2017-07-15

10.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.